"TauRx Announces New Data from Phase 3 AD Study, LUCIDITY, at AAIC 2023"

Learn More

A leader in Alzheimer's disease research

TauRx's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. We are currently conducting clinical trials.

Learn More

Latest news

View all news →